1	Induction	Induction	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	monocytic	monocytic	_	_	_	_	_	_	_
4	differentiation	differentiation	_	_	_	_	_	_	_
5	and	and	_	_	_	_	_	_	_
6	NF-kappa	NF-kappa	_	_	_	_	_	_	_
7	B-like	b-like	_	_	_	_	_	_	_
8	activities	activity	_	_	_	_	_	_	_
9	by	by	_	_	_	_	_	_	_
10	human	human	_	_	_	_	_	_	_
11	immunodeficiency	immunodeficiency	_	_	_	_	_	_	_
12	virus	virus	_	_	_	_	_	_	_
13	1	1	_	_	_	_	_	_	_
14	infection	infection	_	_	_	_	_	_	_
15	of	of	_	_	_	_	_	_	_
16	myelomonoblastic	myelomonoblastic	_	_	_	_	_	_	_
17	cells	cell	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	effects	effect	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	human	human	_	_	_	_	_	_	_
5	immunodeficiency	immunodeficiency	_	_	_	_	_	_	_
6	virus	virus	_	_	_	_	_	_	_
7	1	1	_	_	_	_	_	_	_
8	(	(	_	_	_	_	_	_	_
9	HIV-1	HIV-1	_	_	_	_	_	_	_
10	)	)	_	_	_	_	_	_	_
11	infection	infection	_	_	_	_	_	_	_
12	on	on	_	_	_	_	_	_	_
13	cellular	cellular	_	_	_	_	_	_	_
14	differentiation	differentiation	_	_	_	_	_	_	_
15	and	and	_	_	_	_	_	_	_
16	NF-kappa	NF-kappa	_	_	_	_	_	_	_
17	B	B	_	_	_	_	_	_	_
18	DNA	DNA	_	_	_	_	_	_	_
19	binding	binding	_	_	_	_	_	_	_
20	activity	activity	_	_	_	_	_	_	_
21	have	have	_	_	_	_	_	_	_
22	been	be	_	_	_	_	_	_	_
23	investigated	investigate	_	_	_	_	_	_	_
24	in	in	_	_	_	_	_	_	_
25	a	a	_	_	_	_	_	_	_
26	new	new	_	_	_	_	_	_	_
27	model	model	_	_	_	_	_	_	_
28	of	of	_	_	_	_	_	_	_
29	myeloid	myeloid	_	_	_	_	_	_	_
30	differentiation	differentiation	_	_	_	_	_	_	_
31	.	.	_	_	_	_	_	_	_

1	PLB-985	PLB-985	_	_	_	_	_	_	_
2	cells	cell	_	_	_	_	_	_	_
3	represent	represent	_	_	_	_	_	_	_
4	a	a	_	_	_	_	_	_	_
5	bipotential	bipotential	_	_	_	_	_	_	_
6	myelomonoblastic	myelomonoblastic	_	_	_	_	_	_	_
7	cell	cell	_	_	_	_	_	_	_
8	population	population	_	_	_	_	_	_	_
9	capable	capable	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	either	either	_	_	_	_	_	_	_
12	granulocytic	granulocytic	_	_	_	_	_	_	_
13	or	or	_	_	_	_	_	_	_
14	monocytic	monocytic	_	_	_	_	_	_	_
15	differentiation	differentiation	_	_	_	_	_	_	_
16	after	after	_	_	_	_	_	_	_
17	induction	induction	_	_	_	_	_	_	_
18	with	with	_	_	_	_	_	_	_
19	appropriate	appropriate	_	_	_	_	_	_	_
20	inducers	inducer	_	_	_	_	_	_	_
21	.	.	_	_	_	_	_	_	_

1	By	by	_	_	_	_	_	_	_
2	virtue	virtue	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	presence	presence	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	CD4	cd4	_	_	_	_	_	_	_
8	on	on	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	cell	cell	_	_	_	_	_	_	_
11	surface	surface	_	_	_	_	_	_	_
12	,	,	_	_	_	_	_	_	_
13	PLB-985	PLB-985	_	_	_	_	_	_	_
14	cells	cell	_	_	_	_	_	_	_
15	were	be	_	_	_	_	_	_	_
16	chronically	chronically	_	_	_	_	_	_	_
17	infected	infect	_	_	_	_	_	_	_
18	with	with	_	_	_	_	_	_	_
19	HIV-1	HIV-1	_	_	_	_	_	_	_
20	strain	strain	_	_	_	_	_	_	_
21	IIIB	IIIB	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	PLB-IIIB	PLB-IIIB	_	_	_	_	_	_	_
2	cells	cell	_	_	_	_	_	_	_
3	clearly	clearly	_	_	_	_	_	_	_
4	possessed	possess	_	_	_	_	_	_	_
5	a	a	_	_	_	_	_	_	_
6	more	more	_	_	_	_	_	_	_
7	monocytic	monocytic	_	_	_	_	_	_	_
8	phenotype	phenotype	_	_	_	_	_	_	_
9	than	than	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	parental	parental	_	_	_	_	_	_	_
12	myeloblasts	myeloblast	_	_	_	_	_	_	_
13	,	,	_	_	_	_	_	_	_
14	as	as	_	_	_	_	_	_	_
15	determined	determine	_	_	_	_	_	_	_
16	by	by	_	_	_	_	_	_	_
17	differential	differential	_	_	_	_	_	_	_
18	staining	staining	_	_	_	_	_	_	_
19	,	,	_	_	_	_	_	_	_
20	increased	increase	_	_	_	_	_	_	_
21	expression	expression	_	_	_	_	_	_	_
22	of	of	_	_	_	_	_	_	_
23	the	the	_	_	_	_	_	_	_
24	myeloid-specific	myeloid-specific	_	_	_	_	_	_	_
25	surface	surface	_	_	_	_	_	_	_
26	markers	marker	_	_	_	_	_	_	_
27	,	,	_	_	_	_	_	_	_
28	and	and	_	_	_	_	_	_	_
29	transcription	transcription	_	_	_	_	_	_	_
30	of	of	_	_	_	_	_	_	_
31	the	the	_	_	_	_	_	_	_
32	c-fms	c-fms	_	_	_	_	_	_	_
33	proto-oncogene	proto-oncogene	_	_	_	_	_	_	_
34	.	.	_	_	_	_	_	_	_

1	NF-kappa	NF-kappa	_	_	_	_	_	_	_
2	B	B	_	_	_	_	_	_	_
3	binding	binding	_	_	_	_	_	_	_
4	activity	activity	_	_	_	_	_	_	_
5	was	be	_	_	_	_	_	_	_
6	inducible	inducible	_	_	_	_	_	_	_
7	by	by	_	_	_	_	_	_	_
8	tumor	tumor	_	_	_	_	_	_	_
9	necrosis	necrosis	_	_	_	_	_	_	_
10	factor	factor	_	_	_	_	_	_	_
11	and	and	_	_	_	_	_	_	_
12	phorbol	phorbol	_	_	_	_	_	_	_
13	myristate	myristate	_	_	_	_	_	_	_
14	acetate	acetate	_	_	_	_	_	_	_
15	in	in	_	_	_	_	_	_	_
16	PLB-985	PLB-985	_	_	_	_	_	_	_
17	.	.	_	_	_	_	_	_	_

1	However	however	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	in	in	_	_	_	_	_	_	_
4	PLB-IIIB	PLB-IIIB	_	_	_	_	_	_	_
5	cells	cell	_	_	_	_	_	_	_
6	,	,	_	_	_	_	_	_	_
7	constitutive	constitutive	_	_	_	_	_	_	_
8	expression	expression	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	a	a	_	_	_	_	_	_	_
11	novel	novel	_	_	_	_	_	_	_
12	NF-kappa	NF-kappa	_	_	_	_	_	_	_
13	B	B	_	_	_	_	_	_	_
14	complex	complex	_	_	_	_	_	_	_
15	was	be	_	_	_	_	_	_	_
16	detected	detect	_	_	_	_	_	_	_
17	,	,	_	_	_	_	_	_	_
18	composed	compose	_	_	_	_	_	_	_
19	of	of	_	_	_	_	_	_	_
20	proteins	protein	_	_	_	_	_	_	_
21	ranging	range	_	_	_	_	_	_	_
22	between	between	_	_	_	_	_	_	_
23	70	70	_	_	_	_	_	_	_
24	and	and	_	_	_	_	_	_	_
25	110	110	_	_	_	_	_	_	_
26	kD	kd	_	_	_	_	_	_	_
27	.	.	_	_	_	_	_	_	_

1	These	these	_	_	_	_	_	_	_
2	proteins	protein	_	_	_	_	_	_	_
3	interacted	interact	_	_	_	_	_	_	_
4	specifically	specifically	_	_	_	_	_	_	_
5	with	with	_	_	_	_	_	_	_
6	the	the	_	_	_	_	_	_	_
7	symmetric	symmetric	_	_	_	_	_	_	_
8	NF-kappa	NF-kappa	_	_	_	_	_	_	_
9	B	B	_	_	_	_	_	_	_
10	site	site	_	_	_	_	_	_	_
11	from	from	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	interferon	interferon	_	_	_	_	_	_	_
14	beta	beta	_	_	_	_	_	_	_
15	(	(	_	_	_	_	_	_	_
16	IFN-beta	IFN-beta	_	_	_	_	_	_	_
17	)	)	_	_	_	_	_	_	_
18	promoter	promoter	_	_	_	_	_	_	_
19	.	.	_	_	_	_	_	_	_

1	Mutations	mutation	_	_	_	_	_	_	_
2	affecting	affect	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	5	5	_	_	_	_	_	_	_
5	â€™	'	_	_	_	_	_	_	_
6	guanine	guanine	_	_	_	_	_	_	_
7	residues	residue	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	kappa	kappa	_	_	_	_	_	_	_
11	B	B	_	_	_	_	_	_	_
12	site	site	_	_	_	_	_	_	_
13	were	be	_	_	_	_	_	_	_
14	unable	unable	_	_	_	_	_	_	_
15	to	to	_	_	_	_	_	_	_
16	compete	compete	_	_	_	_	_	_	_
17	for	for	_	_	_	_	_	_	_
18	these	these	_	_	_	_	_	_	_
19	NF-kappa	NF-kappa	_	_	_	_	_	_	_
20	B-related	b-related	_	_	_	_	_	_	_
21	proteins	protein	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	Inducibility	inducibility	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	endogenous	endogenous	_	_	_	_	_	_	_
4	IFN-beta	IFN-beta	_	_	_	_	_	_	_
5	and	and	_	_	_	_	_	_	_
6	IFN-alpha	IFN-alpha	_	_	_	_	_	_	_
7	RNA	RNA	_	_	_	_	_	_	_
8	was	be	_	_	_	_	_	_	_
9	also	also	_	_	_	_	_	_	_
10	increased	increase	_	_	_	_	_	_	_
11	in	in	_	_	_	_	_	_	_
12	PLB-IIIB	PLB-IIIB	_	_	_	_	_	_	_
13	cells	cell	_	_	_	_	_	_	_
14	.	.	_	_	_	_	_	_	_

1	These	these	_	_	_	_	_	_	_
2	studies	study	_	_	_	_	_	_	_
3	indicate	indicate	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	HIV-1	HIV-1	_	_	_	_	_	_	_
6	infection	infection	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	myelomonoblastic	myelomonoblastic	_	_	_	_	_	_	_
9	cells	cell	_	_	_	_	_	_	_
10	may	may	_	_	_	_	_	_	_
11	select	select	_	_	_	_	_	_	_
12	for	for	_	_	_	_	_	_	_
13	a	a	_	_	_	_	_	_	_
14	more	more	_	_	_	_	_	_	_
15	mature	mature	_	_	_	_	_	_	_
16	monocytic	monocytic	_	_	_	_	_	_	_
17	phenotype	phenotype	_	_	_	_	_	_	_
18	and	and	_	_	_	_	_	_	_
19	that	that	_	_	_	_	_	_	_
20	unique	unique	_	_	_	_	_	_	_
21	subunit	subunit	_	_	_	_	_	_	_
22	associations	association	_	_	_	_	_	_	_
23	of	of	_	_	_	_	_	_	_
24	NF-kappa	NF-kappa	_	_	_	_	_	_	_
25	B	B	_	_	_	_	_	_	_
26	DNA	DNA	_	_	_	_	_	_	_
27	binding	binding	_	_	_	_	_	_	_
28	proteins	protein	_	_	_	_	_	_	_
29	may	may	_	_	_	_	_	_	_
30	contribute	contribute	_	_	_	_	_	_	_
31	to	to	_	_	_	_	_	_	_
32	differential	differential	_	_	_	_	_	_	_
33	NF-kappa	NF-kappa	_	_	_	_	_	_	_
34	B-mediated	b-mediated	_	_	_	_	_	_	_
35	gene	gene	_	_	_	_	_	_	_
36	expression	expression	_	_	_	_	_	_	_
37	.	.	_	_	_	_	_	_	_

